Literature DB >> 17255556

Allele-specific binding of airway nuclear extracts to polymorphic beta2-adrenergic receptor 5' sequence.

Alfredo Panebra1, Mary Rose Schwarb, Clare B Glinka, Stephen B Liggett.   

Abstract

Like other intronless G protein-coupled receptor genes, the beta(2)-adrenergic receptor (beta(2)AR) has minimal genetic space for population variability, and has attained such via multiple coding and noncoding polymorphisms. Yet most clinical studies use the two nonsynonymous polymorphisms of the coding region for association analysis despite low levels of linkage disequilibrium with some promoter and 5'UTR polymorphisms. To assess the potential for allele-specific transcription factor binding to beta(2)AR 5'-flanking sequence, 3'-biotin-labeled oligonucleotide duplexes were synthesized. Each was centered on variable sites representing major or minor alleles found in the human population with frequencies of 5% or greater (20 polymorphic sites). Electrophoretic mobility shift assays were performed using human airway smooth muscle or airway epithelial cell nuclear extracts. Many of these polymorphisms resulted in an alteration in binding, and both major allele and minor allele dominance were observed. For example, in airway smooth muscle nuclear extracts, 10 polymorphisms decreased and 2 increased binding, whereas 5 showed no differences. Concordance between airway smooth muscle and epithelial cell nuclear extract binding to polymorphic alleles was found in only approximately 50% of cases. There was no tendency for the rare variants to be more likely to have altered nuclear extract binding compared to the more common variants. Taken together, these results provide potential mechanisms by which beta(2)AR 5'-flanking polymorphisms affect obstructive lung phenotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255556      PMCID: PMC1899344          DOI: 10.1165/rcmb.2006-0394OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  33 in total

Review 1.  Heterogeneity of therapeutic responses in asthma.

Authors:  J M Drazen; E K Silverman; T H Lee
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

2.  Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

Authors:  D R Taylor; J M Drazen; G P Herbison; C N Yandava; R J Hancox; G I Town
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

3.  Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study.

Authors:  Gregory A Hawkins; Kelan Tantisira; Deborah A Meyers; Elizabeth J Ampleford; Wendy C Moore; Barbara Klanderman; Stephen B Liggett; Stephen P Peters; Scott T Weiss; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

4.  Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells.

Authors:  B Lipworth; G H Koppelman; A P Wheatley; I Le Jeune; W Coutie; H Meurs; H F Kauffman; D S Postma; I P Hall
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

5.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.

Authors:  E Israel; J M Drazen; S B Liggett; H A Boushey; R M Cherniack; V M Chinchilli; D M Cooper; J V Fahy; J E Fish; J G Ford; M Kraft; S Kunselman; S C Lazarus; R F Lemanske; R J Martin; D E McLean; S P Peters; E K Silverman; C A Sorkness; S J Szefler; S T Weiss; C N Yandava
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

6.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

Authors:  C M Drysdale; D W McGraw; C B Stack; J C Stephens; R S Judson; K Nandabalan; K Arnold; G Ruano; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

Authors:  S A Green; J Turki; P Bejarano; I P Hall; S B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  1995-07       Impact factor: 6.914

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

9.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

Authors:  S A Green; J Turki; M Innis; S B Liggett
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

10.  A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.

Authors:  S A Green; G Cole; M Jacinto; M Innis; S B Liggett
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

View more
  5 in total

1.  Heterogeneity of transcription factor expression and regulation in human airway epithelial and smooth muscle cells.

Authors:  Alfredo Panebra; Mary Rose Schwarb; Clare B Glinka; Stephen B Liggett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-06-08       Impact factor: 5.464

2.  Expression variation of the porcine ADRB2 has a complex genetic background.

Authors:  Eduard Murani; Siriluck Ponsuksili; Henry Reyer; Dörte Wittenburg; Klaus Wimmers
Journal:  Mol Genet Genomics       Date:  2013-08-31       Impact factor: 3.291

3.  MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation.

Authors:  Wayne C H Wang; Aster H Juan; Alfredo Panebra; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-29       Impact factor: 11.205

Review 4.  The role of ADRB2 gene polymorphisms in malignancies.

Authors:  Yaqian Wang; Shujuan Jiang
Journal:  Mol Biol Rep       Date:  2021-03-06       Impact factor: 2.316

5.  Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia.

Authors:  N Pottier; S W Paugh; C Ding; D Pei; W Yang; S Das; E H Cook; C-H Pui; M V Relling; M H Cheok; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2010-10-27       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.